Tilray Inc(TLRY)
USD --+0.00%
Reward47Moderate
Risk71High
📊75%Data
Thin -252% profit margin
TLRY
+0.0 · +0.00%
USD · NASDAQ
Tilray Inc | Healthcare
Speculative Momentum
Market Cap:916.91M
ℹ️
Reward Rating
47
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
71
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on TLRY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $11.82.

What is Tilray Inc?

, a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

TLRY · Verdict

Moderate reward · high risk

TLRY's standout is valuation; volatility and profitability weigh on the picture.

Based on 88% data coverage

TLRY · Verdict

What’s working & what to watch

Strengths 1

  • Valuation67/100

    P/E 1000.0×

Watchouts 4

  • Volatility5/100

    Weak vs peers

  • Profitability9/100

    -266% net margin · -84% ROE

  • Cash flow25/100

    -16% free-cash-flow margin

  • Balance sheet43/100

    Current ratio 2.46

Model-based scoring. For information only — not financial advice.

What is Tilray Inc?

, a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 916.91M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (47)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap916.91M
P/E RatioN/A
Dividend YieldN/A
52 Week High23.2
52 Week Low3.507
Last AnnualMay
IPO Date7/19/2018
IncorporatedUSA
Shares Outstanding117M
No. of Employees2,842
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNASDAQ
Beta2.11
CurrencyUSD